Searchable abstracts of presentations at key conferences in endocrinology

ea0032p1126 | Thyroid cancer | ECE2013

BRAF V600E mutation in papillary thyroid cancer: clinical and pathological features. Is there any role in tailoring initial treatment?

Oleaga Amelia , Goni Fernando , Paja Miguel , Iglesias Natalia , Fuertes Elena , Lizarraga Aitzol , Palacios Angel Gomez , Elorza Ramon

Introduction: BRAF (V600E) mutation is the most frequent detected genetic change in papillary thyroid cancer (PTC) and its presence has been related to aggressive clinical and pathological features. Lymph node metastases (LNMx) are common in PTC and are associated with an increase in loco-regional recurrence. However, prophylactic lymph node dissection is not routinely performed because of high rate of surgery complications. Therefore, there is a need to find a good marker to ...